{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:20:42Z","timestamp":1792790442644,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10150022310025"],"award-info":[{"award-number":["10150022310025"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The yeast\n                    <jats:italic>Candidozyma auris<\/jats:italic>\n                    has emerged globally as a major threat to public health. Outbreaks are frequently reported and difficult to control. In the Netherlands,\n                    <jats:italic>C. auris<\/jats:italic>\n                    is rarely detected although national surveillance has been set up. Here, we present all Dutch\n                    <jats:italic>C. auris<\/jats:italic>\n                    cases reported from March 2018 until April 2025. Antifungal susceptibility testing (AFST) using broth microdilution and whole genome sequencing (WGS) were conducted to evaluate antifungal resistance and genetic relatedness. A total of 26 cases of\n                    <jats:italic>C. auris<\/jats:italic>\n                    infection or colonization were reported across 22 different medical institutions in the Netherlands. Most patients had a history of travel to countries with prior reports of\n                    <jats:italic>C. auris<\/jats:italic>\n                    and were hospitalized in foreign medical centers. All patients were admitted in isolation, and all but one remained in isolation for the duration of their hospitalization. WGS showed isolates belonged to clade I or III. Analysis of travel history, contact tracing and WGS data showed no evidence of nosocomial transmission. All isolates were non-wild type to fluconazole with many harboring corresponding mutations in\n                    <jats:italic>ERG11<\/jats:italic>\n                    . One isolate was non-wild type to 5FC and another one to echinocandins including rezafungin. The latter harbored a\n                    <jats:italic>FKS1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>F635Y<\/jats:italic>\n                    <\/jats:sup>\n                    mutation and was imported from Greece. To conclude,\n                    <jats:italic>C. auris<\/jats:italic>\n                    cases are steadily increasing in the Netherlands. Nonetheless, until now cases seem solely imported from abroad with no evidence for nosocomial transmission. This can be attributed to effective infection prevention and control policies. The\n                    <jats:italic>C. auris<\/jats:italic>\n                    isolates were all non-wild type for fluconazole and a single isolate was non-wild type for echinocandins.\n                  <\/jats:p>","DOI":"10.1007\/s11046-025-01024-7","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:41:40Z","timestamp":1768012900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Candidozyma auris in The Netherlands: No Evidence of Nosocomial Transmission Supported by Effective Infection Control Policies"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1721-8596","authenticated-orcid":false,"given":"Chiara C.","family":"de Groot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-361X","authenticated-orcid":false,"given":"Bram","family":"Spruijtenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-3017","authenticated-orcid":false,"given":"Juli\u00ebtte A.","family":"Severin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-0778","authenticated-orcid":false,"given":"Jochem B.","family":"Buil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-9860","authenticated-orcid":false,"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-4612","authenticated-orcid":false,"given":"Auke W.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-024X","authenticated-orcid":false,"given":"Eelco F. J.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"1024_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/jof10080558","volume":"10","author":"S Pinho","year":"2024","unstructured":"Pinho S, Miranda IM, Costa-de-Oliveira S. Global Epidemiology of Invasive Infections by Uncommon Candida Species: A Systematic Review. J Fungi. 2024;10:558. https:\/\/doi.org\/10.3390\/jof10080558.","journal-title":"J Fungi"},{"key":"1024_CR2","unstructured":"World Health Organisation (WHO). WHO fungal priority pathogens list to guide research, development and public health action. Geneva; 2022."},{"key":"1024_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106229","volume":"89","author":"J Salmanton-Garc\u00eda","year":"2024","unstructured":"Salmanton-Garc\u00eda J, Cornely OA, Stemler J, Bara\u0107 A, Steinmann J, Siv\u00e1kov\u00e1 A, et al. Attributable mortality of candidemia \u2013 Results from the ECMM Candida III multinational European Observational Cohort Study. J Infect. 2024;89:106229. https:\/\/doi.org\/10.1016\/j.jinf.2024.106229.","journal-title":"J Infect"},{"key":"1024_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-med-061523-021233","volume":"76","author":"EF Eix","year":"2025","unstructured":"Eix EF, Nett JE. Candida auris: Epidemiology and Antifungal Strategy. Annu Rev Med United States. 2025;76:57\u201367. https:\/\/doi.org\/10.1146\/annurev-med-061523-021233.","journal-title":"Annu Rev Med United States"},{"key":"1024_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2807\/1560-7917.ES.2018.23.13.18-00136","volume":"23","author":"A Kohlenberg","year":"2018","unstructured":"Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D. Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. Euro Surveill. 2018;23:18\u201300136. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.13.18-00136.","journal-title":"Euro Surveill"},{"key":"1024_CR6","doi-asserted-by":"publisher","unstructured":"Siopi M, Georgiou P-C, Paranos P, Beredaki M-I, Tarpatzi A, Kalogeropoulou E, et al. Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023. Euro Surveill. Sweden; 2024;29. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.29.2300661","DOI":"10.2807\/1560-7917.ES.2024.29.29.2300661"},{"key":"1024_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/microorganisms12050927","volume":"12","author":"S De Gaetano","year":"2024","unstructured":"De Gaetano S, Midiri A, Mancuso G, Avola MG, Biondo C. Candida auris Outbreaks: Current Status and Future Perspectives. Microorganisms. 2024;12:927. https:\/\/doi.org\/10.3390\/microorganisms12050927.","journal-title":"Microorganisms"},{"key":"1024_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11046-019-00351-w","volume":"184","author":"AW de Jong","year":"2019","unstructured":"de Jong AW, Hagen F. Attack, Defend and Persist: How the Fungal Pathogen Candida auris was Able to Emerge Globally in Healthcare Environments. Mycopathologia. 2019;184:353\u201365. https:\/\/doi.org\/10.1007\/s11046-019-00351-w.","journal-title":"Mycopathologia"},{"key":"1024_CR9","doi-asserted-by":"publisher","unstructured":"Kohlenberg A, Monnet DL, Plachouras D, Group C auris survey collaborative. Increasing number of cases and outbreaks caused by Candida auris in the EU\/EEA, 2020 to 2021. Euro Surveill. European Centre for Disease Prevention and Control; 2022;27:2200846. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.46.2200846","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200846"},{"key":"1024_CR10","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3201\/eid2410.180649","volume":"24","author":"E Adams","year":"2018","unstructured":"Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, Southwick K, et al. Candida auris in Healthcare Facilities, New York, USA, 2013\u20132017. Emerg Infect Dis. 2018;24:1816\u201324. https:\/\/doi.org\/10.3201\/eid2410.180649.","journal-title":"Emerg Infect Dis"},{"key":"1024_CR11","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/JCM.00921-17","volume":"55","author":"RM Welsh","year":"2017","unstructured":"Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. J Clin Microbiol. 2017;55:2996\u20133005. https:\/\/doi.org\/10.1128\/JCM.00921-17.","journal-title":"J Clin Microbiol"},{"key":"1024_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017;64:134\u201340. https:\/\/doi.org\/10.1093\/cid\/ciw691.","journal-title":"Clin Infect Dis"},{"key":"1024_CR13","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1080\/22221751.2022.2125349","volume":"11","author":"B Spruijtenburg","year":"2022","unstructured":"Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect United States. 2022;11:2405\u201311. https:\/\/doi.org\/10.1080\/22221751.2022.2125349.","journal-title":"Emerg Microbes Infect United States"},{"key":"1024_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00101-0","volume":"5","author":"C Suphavilai","year":"2024","unstructured":"Suphavilai C, Ko KKK, Lim KM, Tan MG, Boonsimma P, Chu JJK, et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. The Lancet Microbe. 2024;5:100878. https:\/\/doi.org\/10.1016\/S2666-5247(24)00101-0.","journal-title":"The Lancet Microbe"},{"key":"1024_CR15","doi-asserted-by":"publisher","unstructured":"Chow NA, Mu\u00f1oz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. mBio. 2020;11:e03364\u201319. https:\/\/doi.org\/10.1128\/mBio.03364-19","DOI":"10.1128\/mBio.03364-19"},{"key":"1024_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12879-020-05543-0","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Tian S, Han X, Chu Y, Wang Q, Zhou B, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20:827. https:\/\/doi.org\/10.1186\/s12879-020-05543-0.","journal-title":"BMC Infect Dis"},{"key":"1024_CR17","doi-asserted-by":"publisher","unstructured":"Arendrup MC, Lockhart SR, Wiederhold N. Candida auris MIC testing by EUCAST and clinical and laboratory standards institute broth microdilution, and gradient diffusion strips; to be or not to be amphotericin B resistant? Clin Microbiol Infect. 2024;S1198743X24004920. https:\/\/doi.org\/10.1016\/j.cmi.2024.10.010","DOI":"10.1016\/j.cmi.2024.10.010"},{"key":"1024_CR18","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1016\/s2666-5247(20)30090-2","volume":"1","author":"B O\u2019Brien","year":"2020","unstructured":"O\u2019Brien B, Liang J, Chaturvedi S, Jacobs JL, Chaturvedi V. Pan-resistant Candida auris: New York subcluster susceptible to antifungal combinations. The Lancet Microbe Elsevier BV. 2020;1:e193\u20134. https:\/\/doi.org\/10.1016\/s2666-5247(20)30090-2.","journal-title":"The Lancet Microbe Elsevier BV"},{"key":"1024_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijantimicag.2019.08.013","volume":"54","author":"N Kenters","year":"2019","unstructured":"Kenters N, Kiernan M, Chowdhary A, Denning DW, Pem\u00e1n J, Saris K, et al. Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting. Int J Antimicrob Agents. 2019;54:400\u20136. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.013.","journal-title":"Int J Antimicrob Agents"},{"key":"1024_CR20","doi-asserted-by":"publisher","unstructured":"Meletiadis J, Siopi M, Spruijtenburg B, Georgiou P-C, Kostoula M, Vourli S, et al. Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023. Euro Surveill. 2024;29. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.45.2400128","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400128"},{"key":"1024_CR21","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance Atlas of Infectious Diseases [Internet]. 2023 [cited 2025 May 2]. https:\/\/www.ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases. Accessed 2 May 2025"},{"key":"1024_CR22","doi-asserted-by":"publisher","unstructured":"Meijer EF, Voss A, Meijer E. Should all hospitalised patients colonised with Candida auris be considered for isolation? Euro Surveillance. 2024;29. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.45.2400729","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400729"},{"key":"1024_CR23","unstructured":"Dutch Collaborative Partnership for Infection Prevention Guidelines (SRI). Multidrug-resistant organisms [Internet]. 2024. https:\/\/www.sri-richtlijnen.nl\/brmo"},{"key":"1024_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2024.12.004","author":"LML Dix","year":"2024","unstructured":"Dix LML, Notermans DW, Schneeberger C, van Dijk K. Candida auris in Dutch hospitals: are we ready for it? J Hosp Infect. 2024. https:\/\/doi.org\/10.1016\/j.jhin.2024.12.004.","journal-title":"J Hosp Infect"},{"key":"1024_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/healthcare11030425","volume":"11","author":"N Geremia","year":"2023","unstructured":"Geremia N, Brugnaro P, Solinas M, Scarparo C, Panese S. Candida auris as an Emergent Public Health Problem: A Current Update on European Outbreaks and Cases. Healthcare. 2023;11:425. https:\/\/doi.org\/10.3390\/healthcare11030425.","journal-title":"Healthcare"},{"key":"1024_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhin.2023.12.019","volume":"146","author":"SE Leonhard","year":"2024","unstructured":"Leonhard SE, Chong GM, Foudraine DE, Bode LGM, Croughs P, Popping S, et al. Proposal for a screening protocol for Candida auris colonization. J Hosp Infect. 2024;146:31\u20136. https:\/\/doi.org\/10.1016\/j.jhin.2023.12.019.","journal-title":"J Hosp Infect"},{"key":"1024_CR27","doi-asserted-by":"publisher","unstructured":"Nijhuis RHT, Rispens T, Godschalk PCR. Evaluation of five real-time PCR assays for the detection of Candidozyma auris in clinical specimens. Med Mycol. 2025;63:myaf031. https:\/\/doi.org\/10.1093\/mmy\/myaf031","DOI":"10.1093\/mmy\/myaf031"},{"key":"1024_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof5040091","volume":"5","author":"EH Vogelzang","year":"2019","unstructured":"Vogelzang EH, Weersink AJL, van Mansfeld R, Chow NA, Meis JF, van Dijk K. The First Two Cases of Candida auris in The Netherlands. J Fungi. 2019;5:91. https:\/\/doi.org\/10.3390\/jof5040091.","journal-title":"J Fungi"},{"key":"1024_CR29","unstructured":"J Guinea, J. Meletiadis, S. Arikan-Akdagli, C. Giske, K. Muehlethaler, M. C. Arendrup, et al. Antifungal MIC Method for Yeasts: Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Yeasts [Internet]. 2023 [cited 2025 Apr 21]. https:\/\/www.eucast.org. Accessed 21 Apr 2025"},{"key":"1024_CR30","doi-asserted-by":"crossref","unstructured":"Meletiadis J, Guinea J, Arikan-Akdagli. A multicentre study for determination of epidemiolgical cut off values for Candida auris with EUCAST broth microdilution reference methodology. ESCMID Global 2025, poster O0694; 2025.","DOI":"10.1093\/jac\/dkaf241"},{"issue":"6","key":"1024_CR31","first-page":"10","volume":"61","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother Am Soc Microbiol. 2017;61(6):10\u20131128.","journal-title":"Antimicrob Agents Chemother Am Soc Microbiol"},{"key":"1024_CR32","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs for antifungal agents, version 11.0 [Internet]. 2024. http:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals\/"},{"key":"1024_CR33","doi-asserted-by":"publisher","unstructured":"de Groot T, Spruijtenburg B, Parnell LA, Chow NA, Meis JF. Optimization and Validation of Candida auris Short Tandem Repeat Analysis. Microbiol Spectr. United States; 2022;10:e0264522. https:\/\/doi.org\/10.1128\/spectrum.02645-22","DOI":"10.1128\/spectrum.02645-22"},{"key":"1024_CR34","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/myc.13655","volume":"66","author":"B Spruijtenburg","year":"2023","unstructured":"Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses Germany. 2023;66:1079\u201386. https:\/\/doi.org\/10.1111\/myc.13655.","journal-title":"Mycoses Germany"},{"key":"1024_CR35","doi-asserted-by":"publisher","unstructured":"Erturk Sengel B, Ekren BY, Sayin E, Tukenmez Tigen E, Seydaliyeva A, Cerikcioglu N, et al. Nosocomial infection of C. auris in COVID-19 Intensive Care Unit in T\u00fcrkiye and Phylogenetic Analysis of Isolates. Mycopathologia. Netherlands; 2023;188:765\u201373. https:\/\/doi.org\/10.1007\/s11046-023-00782-6","DOI":"10.1007\/s11046-023-00782-6"},{"key":"1024_CR36","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S1473-3099(18)30597-8","volume":"18","author":"NA Chow","year":"2018","unstructured":"Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, et al. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis. 2018;18:1377\u201384. https:\/\/doi.org\/10.1016\/S1473-3099(18)30597-8.","journal-title":"Lancet Infect Dis"},{"key":"1024_CR37","doi-asserted-by":"publisher","unstructured":"Korsten K, Gerrits van den Ende B, Pique RD, Hagen F, van Dijk K. Keep the Hospital Clean: Diagnostic Performance of Ten Different Molecular and Culture-Based Methods to Detect Candidozyma (Candida) auris. Mycopathologia. 2025;190:37. https:\/\/doi.org\/10.1007\/s11046-025-00944-8","DOI":"10.1007\/s11046-025-00944-8"},{"key":"1024_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70065","volume":"68","author":"JB Buil","year":"2025","unstructured":"Buil JB, van den Bosch B, van der Maas SJ, Meijer EFJ, de Groot T, Meletiadis J, et al. Performance Evaluation of Five Real-Time PCR Assays for the Detection of Candida auris DNA. Mycoses. 2025;68:e70065. https:\/\/doi.org\/10.1111\/myc.70065.","journal-title":"Mycoses"},{"key":"1024_CR39","first-page":"81","volume":"33","author":"C de Groot","year":"2025","unstructured":"de Groot C, de Jong A, Severin J, Voss A, Verweij P, Meijer E, et al. Candida auris Nationale Stakeholder Meeting onderdeel van het CAUTION project. Ned Tijdschr Med Microbiol. 2025;33:81\u20138.","journal-title":"Ned Tijdschr Med Microbiol"},{"key":"1024_CR40","doi-asserted-by":"publisher","unstructured":"Chavez J, Crank K, Barber C, Gerrity D, Iverson T, Mongillo J, et al. Early Introductions of Candida auris Detected by Wastewater Surveillance, Utah, USA, 2022\u20132023. Emerg Infect Dis. 2024;30. https:\/\/doi.org\/10.3201\/eid3010.240173","DOI":"10.3201\/eid3010.240173"},{"key":"1024_CR41","doi-asserted-by":"publisher","unstructured":"Zulli A, Chan EMG, Shelden B, Duong D, Xu X-RS, White BJ, et al. Prospective study of Candida auris nucleic acids in wastewater solids in 190 wastewater treatment plants in the United States suggests widespread occurrence. mBio. 2024;15:e00908\u201324. https:\/\/doi.org\/10.1128\/mbio.00908-24","DOI":"10.1128\/mbio.00908-24"},{"key":"1024_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2022.102208","volume":"70","author":"JM Rybak","year":"2022","unstructured":"Rybak JM, Cuomo CA, David RP. The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris. Curr Opin Microbiol. 2022;70:102208. https:\/\/doi.org\/10.1016\/j.mib.2022.102208.","journal-title":"Curr Opin Microbiol"},{"key":"1024_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dkx480","volume":"73","author":"A Chowdhary","year":"2018","unstructured":"Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009\u201317) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73:891\u20139. https:\/\/doi.org\/10.1093\/jac\/dkx480.","journal-title":"J Antimicrob Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-025-01024-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:03:04Z","timestamp":1771099384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-025-01024-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s11046-025-01024-7","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EFJM received research grants from Mundipharma and Scynexis, is on the scientific advisory board for Pfizer and has received speaker fees from Gilead Sciences. KD received a speaker\u2019s fee and an advisory board fee from Pfizer and a speaker\u2019s fee and an advisory board fee from Gilead. JBB received research grants from bioM\u00e9rieux, advisory board fee from Shinogi and Gilead and speaker fees from Pfizer. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was required according to the Dutch Framework for the assessment of medical-scientific research not subject to the WMO by the Ministry of Health, Welfare and Sport. The COREON code of conduct for health research has been followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17"}}